Skip to main content
. 2022 Jun 28;22:522. doi: 10.1186/s12884-022-04828-3

Table 2.

Ovarian stimulation outcomes in three groups

Item Control Nonsurgery Surgery P value
Gn initial dosage, IU 273.31 ± 67.41 286.84 ± 95.44 293.31 ± 82.89 0.471
Duration of Gn stimulation, d 8.98 ± 2.01 9.39 ± 2.55 8.59 ± 2.25 0.254
Total dosage of Gn per cycle, IU 2438.92 ± 788.71 2807.23 ± 935.16 2654.73 ± 811.35 0.065
Average transfer endometrial thickness, mm 9.67 ± 1.52 9.64 ± 2.17 10.17 ± 1.96 0.944
Oocytes MII retrieved, n 19.92 ± 7.12a 9.47 ± 6.32b 12.32 ± 9.19c 0.000
High-quality embryo rate 39.10 ± 26.10 35.12 ± 29.74 36.40 ± 28.72 0.740
Cycle of transfer 0.020
 Fresh embryo transfer cycle 30 (28.0) 43 (44.8)a 19 (27.9)b
 Frozen-thawed embryo transfer cycle 77 (72.0) 53 (55.2) 49 (72.1)
Protocol of ovary stimulation 0.539
 Short protocol 3 (4.9) 4 (6.8) 4 (9.5)
 Long protocol 40 (65.6) 33 (55.9) 27 (64.3)
 GnRH-A protocol 18 (29.5) 19 (32.2) 10 (23.8)
 Natural-cycle protocol 0 (0) 3 (5.1) 1 (2.4)
Endometrium preparation protocol 0.719
 Natural-cycle 64 (83.1) 42 (79.2) 38 (76.7)
 HRT 13 (16.9) 11 (20.8) 11 (22.4)
Patients undergoing embryo transfer 0.332
 Cleavage transfer rate 98(91.6) 88(91.7) 58 (85.3)
 Blastocyst transfer rate 9 (8.4) 7 (7.3) 10 (14.7)
 Sequential transfer rate 0 (0) 1 (1.1) 0 (0)
High-quality embryo transferred rate 84 (78.5) 65 (67.7) 46 (67.6) 0.153
No. of embryos transferred, n 1.77 ± 0.47 1.74 ± 0.57 1.66 ± 0.51 0.415
Average transfer times to live birth, times 1 (1,2) 2 (1,2) 1 (1,1)c 0.023

Values are presented as the mean standard deviation, n (%) or median (lower quartile, upper quartile)

Gn Gonadotropin, GnRH-A Gonadotropin Releasing Hormone Antagonist, HRT Hormone Replacement Treatment cycle

a shows that there were significant differences between the nonsurgery group and the control group

b shows that there were significant differences between the surgery group and the control group

c shows that there were significant differences between the surgery group and the nonsurgery group